Sema4 President and COO James Coffin departs; gets $550K severance, bonus, option acceleration

GeneDx Holdings Corp.

James Coffin, President and COO, leaves for personal reasons effective Feb 1, 2022.
Separation agreement includes $550,000 cash severance (12 months base salary) and $180,370 bonus.
COBRA premiums reimbursed for up to 12 months; accelerated vesting of 25,425 stock options.
Extended post-termination exercise period for vested options through May 30, 2022.
CEO Eric Schadt will absorb Coffin's responsibilities; no successor named.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James Coffin

President and Chief Operating Officer

WGS · GeneDx Holdings Corp.

Effective: 2022-02-01
Filed: January 31, 2022, 6:59 PM ET

James Coffin, Ph.D., the President and Chief Operating Officer of Sema4 Holdings Corp. (the “Company”), will leave the Company for personal reasons, effective February 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Coffin departed as President and Chief Operating Officer at GeneDx Holdings Corp..

Action: departed
Role: President and Chief Operating Officer

Exact text from the filing

James Coffin, Ph.D., the President and Chief Operating Officer of Sema4 Holdings Corp. (the “Company”), will leave the Company for personal reasons, effective February 1, 2022.

View on SEC.gov

GeneDx Holdings Corp. filing history →

Source: SEC EDGAR

accession 0001818331-22-000022

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.